Skip to main content
Clinical Trials/CTRI/2019/02/017458
CTRI/2019/02/017458CompletedPhase 3

An Open label Non-randomized Single arm clinical study to evaluate efficacy of Somvalkal Kashay Siddha Basti in Prameha

Dr Nakul Khode0 sites31 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Completed
Sponsor
Enrollment
31

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Patients with symptoms of Prameha as per Ayurvedic classics and Type 2 diabetes mellitus as per modern medicine
  • Age group between 30 to 60 years
  • HbA1c value will 6.5 percentage or above
  • Patients taking Biguanides group anti-diabetic drugs
  • Fasting blood sugar level within 150 mgdl and Post prandial blood sugar within 250 mgdl

Exclusion Criteria

  • HbA1c values will less than 6.5 percentage
  • Patients taking other than Biguanides group anti diabetic drugs
  • Patients of Insulin dependent diabetes mellitus
  • Diabetes due to Endocrinopathies for eg Pheochromocytoma Acromegaly Cushing syndrome
  • Drugs or chemical induced diabetes mellitus eg Glucocorticoids thyroid hormone Thiazide Phenytoin etc
  • Patients with other systemic complication like cardiovascular nephropathic diseases etc
  • Basti Anarha

Investigators

Sponsor
Dr Nakul Khode

Similar Trials